Plain-English translation of NCT05608434 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This research trial is testing a new virtual reality-based training program called Floreo VR designed to help children and teenagers ages 8–16 with attention deficit hyperactivity disorder (ADHD), particularly those who struggle with inattention. The study will first run a smaller pilot phase to make sure the treatment is safe and works as intended, followed by a larger main trial where some participants will use the adaptive VR training while others use a simpler version. Researchers will measure whether this training helps improve attention symptoms and how well young people perform on thinking and problem-solving tasks.
Current treatments for ADHD symptoms related to attention work in different ways for different young people, and researchers are looking for new tools that might strengthen the brain skills involved in focus and concentration. This trial exists to see if an interactive, engaging virtual reality approach might be a helpful addition to how we treat inattention in children and teenagers.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would first complete a screening visit where doctors check whether the VR headset is comfortable for you and gather information about your attention and thinking skills. Then you would come in for up to 20 daily sessions (each lasting about 20 minutes) where you use the virtual reality training program. After finishing, you would return for final testing to see how the training affected your attention and thinking abilities. Some participants will also have their ADHD medications paused during certain parts of the study so researchers can see the true effects of the VR training.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States